Methylglyoxal: The Antibacterial Compound Behind Medical-Grade Manuka

Understanding the Molecule That Changed Wound Care

What Makes Manuka Different

All honey has some antibacterial properties from hydrogen peroxide produced by the enzyme glucose oxidase. Manuka honey also contains methylglyoxal (MGO), which researchers have identified as the main driver of its non-peroxide antibacterial activity in laboratory studies. Peroxide activity can be broken down by enzymes in tissue, while MGO activity does not depend on peroxide. Lab results like these do not by themselves show better healing in patients.

The MGO Formation Pathway

Methylglyoxal does not exist in Manuka flower nectar. Instead, the nectar contains high concentrations of dihydroxyacetone (DHA), a simple sugar molecule produced by Leptospermum scoparium plants. While the chemical conversion is internal to the honey, the initial DHA levels are dictated by the environment. Explore our MGO Terroir Mapping to see how specific soil chemistry and regional climate patterns dictate the potential potency of the final harvest. When bees collect this nectar and store it in the hive, the DHA undergoes a non-enzymatic chemical reaction that slowly converts it into methylglyoxal.

The Chemical Reaction

Dihydroxyacetone (DHA) undergoes slow dehydration in the acidic honey environment, losing a water molecule to become methylglyoxal (MGO). This reaction is accelerated by heat and acidity. A single Leptospermum scoparium blossom can produce nectar with DHA concentrations exceeding 2000 mg/kg, which eventually converts to MGO levels between 100 and 1000+ mg/kg depending on storage conditions and duration.

How MGO Kills Bacteria

Methylglyoxal is a reactive carbonyl compound that can damage bacterial proteins and DNA through a process called glycation. In lab studies it acts on several cell components at once, rather than a single pathway like many antibiotics, which may make resistance harder to develop. Harder is not impossible: a 2014 study recovered Pseudomonas aeruginosa from honey-treated biofilms that were less susceptible to manuka honey.

Protein Damage

MGO binds to lysine and arginine residues in bacterial proteins, creating Advanced Glycation End-products (AGEs) that disrupt enzyme function and membrane integrity.

DNA Crosslinking

MGO reacts with guanine bases in bacterial DNA, forming covalent bonds that prevent replication and transcription, effectively halting bacterial reproduction.

MGO Concentration and Clinical Efficacy

Laboratory studies generally find that antibacterial activity rises as MGO concentration rises. No single MGO level has been shown to produce better healing in patients, and the rating guide below describes labels on jars, not treatment advice.

MGO Rating Guide

MGO 100+
Lower Labeled MGO

Common in everyday jars and usually the lowest price. Honey sold as food is not a wound dressing at any MGO level.

MGO 400+
Mid-Range Labeled MGO

A common choice for daily eating. Honey sold as food is not sterile, and a food jar is not made for wounds.

MGO 800+
High Labeled MGO

Premium jars that cost much more per gram. We have no evidence that a higher MGO number gives a better result for any particular use.

Understanding UMF vs MGO Ratings

UMF (Unique Manuka Factor) is a rating system run by the UMF Honey Association that tests MGO, DHA, leptosperin and other markers. MGO is a direct chemical measurement in milligrams per kilogram. The association publishes a minimum MGO for each UMF grade, such as at least 826 mg/kg for UMF 20+, but says the two scales are not interchangeable. See our MGO and UMF guide for the full table.

Live Citation Tracker: MGO Research Impact

The following citations represent the foundational research on methylglyoxal in Manuka honey. These papers established MGO as the primary antibacterial component and remain the most referenced works in the field. Citation counts update automatically to show current scientific interest.

Loading citation data from Semantic Scholar...

Laboratory Evidence vs Clinical Application

Most MGO research comes from in-vitro studies where bacteria are cultured in laboratory dishes and exposed to controlled honey concentrations. These studies prove that MGO has antibacterial activity, but translating laboratory results to clinical wound healing is more complex.

In actual wounds, honey is diluted by wound exudate, MGO concentrations fluctuate, and bacterial biofilms can protect organisms from direct exposure. That gap between laboratory results and clinical outcomes is one reason lab findings should be read with caution.

The Translation Challenge

Honey that shows strong antibacterial activity in a laboratory test may behave differently in a wound, because dilution by exudate can lower MGO concentration. Clinical protocols vary on how much honey to use and how often to change dressings, and the evidence for specific schedules is limited.

The Biochemistry of Methylglyoxal in Manuka Honey

An audio overview of methylglyoxal chemistry in manuka honey and the dilution effect in wound care. The recording is a conversation, not a source. Check the citations on this page for the evidence.

Continue Learning

Understanding MGO mechanism is essential, but clinical efficacy depends on how this compound works alongside other honey properties in real wound environments.